Reshaping Organizational Culture in Pathology.
“Transforming Pathology Culture: Emphasizing collaboration, AI, and diversity for enhanced diagnostic accuracy and team growth. ππ€”
August 17, 2025
Follow us
latest articles
Discover the newest research about AI innovations in π§ͺ Pathology.
Implication of Bimodal Magnetic Resonance and Fluorescence Imaging Probes in Advanced Healthcare: Enhancing Disease Diagnosis and Targeted Therapy.
Bimodal imaging probes enhance disease diagnosis and therapy, combining MRI and fluorescence for improved precision. π§¬π¬
August 4, 2025
Automating Colon Polyp Classification in Digital Pathology by Evaluation of a “Machine Learning as a Service” AI Model: Algorithm Development and Validation Study.
AI in Colon Polyp Classification: 100% Accuracy Achieved! π€π
August 1, 2025
AI Model Enhances Tumor Detection in Breast MRI
AI model improves tumor detection in breast MRI, enhancing accuracy and efficiency for better cancer screening. π©Ίπ
July 28, 2025
AI Enhances Pathologists’ Analysis of Skin Cancer Tissue Samples
AI improves pathologists’ analysis of skin cancer tissue samples, enhancing consistency and accuracy in patient prognoses. π©Ίπ
July 21, 2025
AI Enhances Cancer Treatment Matching for Pathologists
AI improves cancer treatment matching for pathologists, enhancing tumor sample analysis and potentially reducing genetic testing needs. π§¬π»
July 20, 2025
Sora Neuroscience’s Cirrus Brain Mapping Software Receives FDA Approval
Sora Neuroscience’s Cirrus brain mapping software has received FDA approval, aiding neurosurgeons in surgical planning. π§ β
June 30, 2025
Personalized translational medicine: Investigating YKL-40 as early biomarker for clinical risk stratification in hepatocellular carcinoma recurrence post-liver transplantation.
YKL-40 shows promise as a biomarker for HCC recurrence post-liver transplantation, enhancing risk stratification. ππ
June 19, 2025
Systematic scoping review of external validation studies of AI pathology models for lung cancer diagnosis.
AI models for lung cancer diagnosis show AUC values from 0.746 to 0.999, but require more robust external validation. ππ©Ί
June 8, 2025
Identification of a novel chemotherapy benefit index for patients with advanced ovarian cancer based on Bayesian network analysis.
Novel Chemotherapy Benefit Index for Advanced Ovarian Cancer: Key Genes, Survival Rates, and Immunotherapy Insights ππ
May 28, 2025